170 related articles for article (PubMed ID: 19826414)
1. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
2. U19/Eaf2 binds to and stabilizes von hippel-lindau protein.
Xiao W; Ai J; Habermacher G; Volpert O; Yang X; Zhang AY; Hahn J; Cai X; Wang Z
Cancer Res; 2009 Mar; 69(6):2599-606. PubMed ID: 19258512
[TBL] [Abstract][Full Text] [Related]
3. ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.
Xiao W; Jiang F; Wang Z
Prostate; 2006 Jan; 66(1):1-12. PubMed ID: 16114057
[TBL] [Abstract][Full Text] [Related]
4. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
Hahn J; Xiao W; Jiang F; Simone F; Thirman MJ; Wang Z
Prostate; 2007 Feb; 67(2):146-53. PubMed ID: 17044034
[TBL] [Abstract][Full Text] [Related]
6. Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19.
Wan X; Ji W; Mei X; Zhou J; Liu JX; Fang C; Xiao W
PLoS One; 2010 Feb; 5(2):e9118. PubMed ID: 20161747
[TBL] [Abstract][Full Text] [Related]
7. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
Xiao W; Zhang Q; Habermacher G; Yang X; Zhang AY; Cai X; Hahn J; Liu J; Pins M; Doglio L; Dhir R; Gingrich J; Wang Z
Oncogene; 2008 Mar; 27(11):1536-44. PubMed ID: 17873910
[TBL] [Abstract][Full Text] [Related]
8. Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells.
Qiao Z; Wang D; Hahn J; Ai J; Wang Z
Prostate; 2014 Feb; 74(2):113-20. PubMed ID: 24272884
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.
Su F; Correa BR; Luo J; Vencio RZ; Pascal LE; Wang Z
Cancer Microenviron; 2013 Dec; 6(3):247-61. PubMed ID: 23440596
[TBL] [Abstract][Full Text] [Related]
10. FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.
Jiang F; Ai J; Xiao W; Wang Z
Cancer Lett; 2007 Aug; 253(2):265-72. PubMed ID: 17395368
[TBL] [Abstract][Full Text] [Related]
11. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
[TBL] [Abstract][Full Text] [Related]
12. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.
Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z
Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067
[TBL] [Abstract][Full Text] [Related]
13. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.
Pascal LE; Wang Y; Zhong M; Wang D; Chakka AB; Yang Z; Li F; Song Q; Rigatti LH; Chaparala S; Chandran U; Parwani AV; Wang Z
Neoplasia; 2018 Apr; 20(4):351-363. PubMed ID: 29518696
[TBL] [Abstract][Full Text] [Related]
14. The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1.
Mallakin A; Sugiyama T; Kai F; Taneja P; Kendig RD; Frazier DP; Maglic D; Matise LA; Willingham MC; Inoue K
Int J Cancer; 2010 Mar; 126(6):1403-16. PubMed ID: 19816943
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
Laderoute KR; Alarcon RM; Brody MD; Calaoagan JM; Chen EY; Knapp AM; Yun Z; Denko NC; Giaccia AJ
Clin Cancer Res; 2000 Jul; 6(7):2941-50. PubMed ID: 10914744
[TBL] [Abstract][Full Text] [Related]
16. Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.
Zhou J; Feng X; Ban B; Liu J; Wang Z; Xiao W
J Biol Chem; 2009 Jul; 284(28):19142-52. PubMed ID: 19447890
[TBL] [Abstract][Full Text] [Related]
17. Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2016 May; 7(20):29245-54. PubMed ID: 27058417
[TBL] [Abstract][Full Text] [Related]
18. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.
Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G
Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858
[TBL] [Abstract][Full Text] [Related]
19. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.
Cinatl J; Kotchetkov R; Scholz M; Cinatl J; Vogel JU; Driever PH; Doerr HW
Am J Pathol; 1999 Jul; 155(1):285-92. PubMed ID: 10393860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
